Sue-Chue-Lam, C.; Brezden-Masley, C.; Sutradhar, R.; Yu, A.Y.X.; Baxter, N.N.
The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based Retrospective Cohort Study. Curr. Oncol. 2023, 30, 6508-6532.
https://doi.org/10.3390/curroncol30070478
AMA Style
Sue-Chue-Lam C, Brezden-Masley C, Sutradhar R, Yu AYX, Baxter NN.
The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based Retrospective Cohort Study. Current Oncology. 2023; 30(7):6508-6532.
https://doi.org/10.3390/curroncol30070478
Chicago/Turabian Style
Sue-Chue-Lam, Colin, Christine Brezden-Masley, Rinku Sutradhar, Amy Y. X. Yu, and Nancy N. Baxter.
2023. "The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based Retrospective Cohort Study" Current Oncology 30, no. 7: 6508-6532.
https://doi.org/10.3390/curroncol30070478
APA Style
Sue-Chue-Lam, C., Brezden-Masley, C., Sutradhar, R., Yu, A. Y. X., & Baxter, N. N.
(2023). The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based Retrospective Cohort Study. Current Oncology, 30(7), 6508-6532.
https://doi.org/10.3390/curroncol30070478
